Gossamer Bio reported a net margin of -308.63% for the quarter ended Jun 2026. These financial ratios cover 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||
| EBT Margin | 56.00% | -336.87% | -377.85% | -397.03% | -333.13% | -362.73% | -342.97% | -278.78% | -308.63% | |||||||||||||||||||||
| EBIT Margin | 54.35% | -357.80% | -385.20% | -372.23% | -337.41% | -369.44% | -333.64% | -264.62% | -282.25% | |||||||||||||||||||||
| EBITDA Margin | 54.35% | -357.80% | -385.20% | -372.23% | -337.41% | -369.44% | -333.64% | -264.62% | -282.25% | |||||||||||||||||||||
| Operating Margin | 54.35% | -357.80% | -385.20% | -372.23% | -337.41% | -369.44% | -333.64% | -264.62% | -282.25% | |||||||||||||||||||||
| Net Margin | 51.37% | -324.93% | -352.16% | -397.03% | -333.13% | -362.73% | -342.33% | -278.78% | -308.63% | |||||||||||||||||||||
| FCF Margin | 121.40% | -337.90% | -378.30% | -401.96% | -410.08% | -272.06% | -350.13% | -228.38% | -426.76% | |||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 409.77M | 365.35M | 319.17M | 270.26M | 284.69M | 297.99M | 246.18M | 200.83M | 264.84M | 329.92M | 285.64M | 316.40M | 362.16M | 333.09M | 297.94M | 260.76M | 224.87M | 190.53M | 150.57M | 102.88M | ||||||||||
| Invested CapitalInvested Cap. | 198.80M | 150.54M | 59.33M | 1.18M | 71.19M | 35.68M | -7.62M | -44.75M | 119.86M | 75.20M | 36.31M | 81.53M | 54.14M | 29.49M | -122.76M | -57.88M | ||||||||||||||
| Asset Utilization RatioAsset Util. | 0.30 | 0.29 | 0.34 | 0.42 | 0.15 | 0.20 | 0.25 | 0.37 | 0.52 | |||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -11.39 | -10.46 | -15.67 | -15.48 | -16.12 | -15.72 | -13.70 | -13.50 | -12.11 | -15.14 | -13.41 | 17.86 | -12.41 | -13.20 | -13.40 | -14.13 | -17.87 | -16.74 | -16.29 | -9.64 | ||||||||||
| Debt Ratio | 0.07 | 0.08 | 0.10 | 0.07 | 0.05 | 0.09 | 0.09 | 0.10 | 0.04 | 0.04 | 0.04 | 0.47 | ||||||||||||||||||
| Times Interest Earned | -11.39 | -10.46 | -15.67 | -15.48 | -16.12 | -15.72 | -13.70 | -13.50 | -12.11 | -15.14 | -13.41 | 17.86 | -12.41 | -13.20 | -13.40 | -14.13 | -17.87 | -16.74 | -16.29 | -9.64 | ||||||||||
| Valuation | ||||||||||||||||||||||||||||||
| Price to EarningsP/E | -15.68 | -15.20 | -11.42 | -11.26 | -19.06 | -3.58 | -2.36 | -2.70 | -4.68 | -2.88 | -5.97 | 4.14 | -7.28 | -6.17 | -6.37 | -7.31 | -12.62 | -15.34 | -1.64 | -1.80 | ||||||||||
| Price to SalesP/S | 2.12 | 23.66 | 21.74 | 25.27 | 24.34 | 45.76 | 52.50 | 4.57 | 5.54 | |||||||||||||||||||||
| Price to BookP/B | 5.57 | 7.05 | 22.03 | -39.02 | 19.97 | 16.97 | -4.23 | -1.82 | 1.79 | 2.21 | 9.99 | 2.50 | 4.14 | 6.92 | -39.99 | -6.06 | -7.39 | -5.90 | -0.48 | -0.54 | ||||||||||
| Enterprise Value | 580.50M | 531.54M | 392.87M | 420.12M | 820.71M | -50.78M | -81.60M | -47.58M | -141.80M | -157.54M | 22.54M | -150.88M | -102.70M | -90.57M | -7.99M | 66.69M | 428.11M | 587.47M | -21.77M | -5.82M | ||||||||||
| EV to EBIT | -10.43 | -10.29 | -7.23 | -7.80 | -14.65 | 0.93 | 1.70 | 1.03 | 3.50 | 3.21 | -0.54 | -2.90 | 3.03 | 2.51 | 0.22 | -1.72 | -8.72 | -12.76 | 0.49 | 0.22 | ||||||||||
| EV to EBITDA | -10.43 | -10.29 | -7.23 | -7.80 | -14.65 | 0.93 | 1.70 | 1.03 | 3.50 | 3.21 | -0.54 | -2.90 | 3.03 | 2.51 | 0.22 | -1.72 | -8.72 | -12.76 | 0.49 | 0.22 | ||||||||||
| Market Capitalization | 946.52M | 856.76M | 664.49M | 642.28M | 1,125.09M | 204.90M | 120.26M | 114.54M | 187.09M | 138.89M | 266.94M | 203.60M | 224.34M | 203.94M | 249.94M | 279.61M | 608.34M | 724.40M | 77.45M | 51.20M | ||||||||||
| Price to FCFP/FCF | -22.24 | -21.11 | -12.39 | -13.12 | -30.38 | -4.28 | -2.27 | -2.99 | -5.42 | -4.16 | -5.10 | 1.75 | -7.00 | -5.75 | -6.29 | -5.93 | -16.82 | -14.99 | -2.00 | -1.30 | ||||||||||
| EV to FCF | -13.64 | -13.09 | -7.32 | -8.58 | -22.16 | 1.06 | 1.54 | 1.24 | 4.11 | 4.71 | -0.43 | -1.30 | 3.21 | 2.55 | 0.20 | -1.42 | -11.84 | -12.16 | 0.56 | 0.15 | ||||||||||
| EV to CFO | -13.81 | -13.12 | -7.35 | -8.61 | -22.18 | 1.06 | 1.54 | 1.24 | 4.11 | 4.71 | -0.43 | -1.30 | 3.21 | 2.55 | 0.20 | -1.42 | -11.84 | -12.16 | 0.56 | 0.15 | ||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 54.35% | -357.80% | -385.20% | -372.23% | -337.41% | -369.44% | -333.64% | -264.62% | -282.25% | |||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -60.06% | -66.40% | -76.34% | -95.43% | -93.04% | -87.87% | -103.20% | -127.34% | -84.98% | -66.02% | -71.16% | -29.27% | -23.41% | -20.80% | -21.93% | -70.29% | -98.81% | -134.33% | -190.06% | 475.91% | ||||||||||
| Return on Invested Capital [ROIC]ROIC | -142.28% | -112.33% | -145.49% | |||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -59.28% | -64.27% | -73.69% | -85.83% | -81.01% | -77.68% | -91.06% | -104.37% | -71.96% | -55.02% | -61.40% | -26.44% | -20.56% | -17.82% | -18.08% | -54.21% | -70.61% | -90.79% | -120.21% | -166.44% |